LIMN
#4900
Liminatus Pharma, Inc. - Class A Common Stock
4.2 3 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.86%
Changement Mensuel
+3745.45%
Evolution sur 6 mois
+1592.00%
Changement Annuel
+43.39%
Clôture Précédente
4.4 0
Open
4.2 3
Low
4.2 3
High
4.2 3
Volume
9
Financials
- Market Capitalization 5.68 M
- Employee 1
- Founded 2020
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4894 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.06 USD | -3.29% | -2.37% | +7.85% | -7.41% | 5.75 M USD | ||
| 4898 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.86 USD | -3.37% | -2.27% | -1.15% | -85.67% | 5.70 M USD | ||
| 4901 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.18 USD | -75.00% | -77.50% | -77.22% | -88.61% | 5.63 M USD | ||
| 4909 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.52 USD | -3.70% | -1.89% | -11.86% | -48.00% | 5.58 M USD |